240
Views
6
CrossRef citations to date
0
Altmetric
Review

Role of the levonorgestrel intrauterine system in effective contraception

, &
Pages 777-785 | Published online: 09 Aug 2013

References

  • GrimesDAIntrauterine device and upper-genital-tract infectionLancet200035692341013101911041414
  • SondheimerSJOral contraceptives: mechanism of action, dosing, safety, and efficacyCutis200881Suppl 1192218338654
  • World Health OrganizationMedical Eligibility Criteria for Contraceptive Use4th edGenevaWHO2010
  • TrussellJVaughanBContraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family GrowthFam Plann Perspect199931264729310224544
  • StanczykFZHenzlMRUse of the name “Progestin”Contraception20016411211535205
  • RoseSChaudhariAPetersonCMMirena (levonorgestrel intrauterine system): a successful novel drug delivery option in contraceptionAdv Drug Deliv Rev2009611080881219445984
  • Samra-LatifOMContraception2013 Available from: http://emedicine.medscape.com/article/258507-overviewAccessed July 17, 2013
  • LuukkainenTLahteenmakiPToivonenJLevonorgestrel-releasing intrauterine deviceAnn Med199022285902113816
  • LahteenmakiPRauramoIBackmanTThe levonorgestrel intrauterine system in contraceptionSteroids20006510–1169369711108878
  • DeanGGoldbergABOverview of intrauterine contraception2013 Available from: http://www.uptodate.com/contents/overview-of-intrauterine-contraception?source=see_linkAccessed July 19, 2013
  • BenagianoGPrimieroFMFarrisMClinical profile of contraceptive progestinsEur J Contracept Reprod Health Care20049318219315697108
  • Sitruk-WareRNew progestagens for contraceptive useHum Reprod Update200612216917816291771
  • BenagianoGCarraraSFilippiVSafety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptivesPatient Prefer Adherence2009313114319936155
  • RowlandsSNewer progestogensJ Fam Plann Reprod Health Care2003291131612626173
  • Sitruk-WareRNew progestogens: a review of their effects in perimenopausal and postmenopausal womenDrugs Aging2004211386588315493951
  • SchindlerAECampagnoliCDruckmannRClassification and pharmacology of progestinsMaturitas200346 Suppl 1S7S1614670641
  • StanczykFZRoySMetabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroidsContraception199042167962143719
  • NilssonCGLahteenmakiPLLuukkainenTRobertsonDNSustained intrauterine release of levonorgestrel over five yearsFertil Steril19864568058073086130
  • KlaisleCMWysockiSInnovations in contraception: the Norplant systemNAACOGS Clin Issu Perinat Womens Health Nurs1992322672791596435
  • SilverbergSGHaukkamaaMArkoHNilssonCGLuukkainenTEndometrial morphology during long-term use of levonorgestrel-releasing intrauterine devicesInt J Gynecol Pathol1986532352413093395
  • CritchleyHOWangHKellyRWGebbieAEGlasierAFProgestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine systemHum Reprod1998135121012179647549
  • AnderssonKOdlindVRyboGLevonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trialContraception199449156728137626
  • OrtizMECroxattoHBCopper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of actionContraception200775Suppl 6S16S3017531610
  • GuillebaudJThe levonorgestrel intrauterine system: a clinical perspective from the UKAnn N Y Acad Sci200399718519314644825
  • SivinISternJCoutinhoEProlonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDSContraception19914454734801797462
  • CoxMTrippJBlacksellSClinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year reportJ Fam Plann Reprod Health Care2002282737712396776
  • FrenchRVan VlietHCowanFHormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancyCochrane Database Syst Rev20043CD00177615266453
  • ChiouCFTrussellJReyesEEconomic analysis of contraceptives for womenContraception200368131012878280
  • CarusiDAGoldbergABInsertion and removal of an intrauterine contraceptive device2013 Available from: http://www.uptodate.com/contents/insertion-and-removal-of-an-intrauterine-contraceptive-device?source=see_linkAccessed July 19, 2013
  • ChenBAReevesMFHayesJLHohmannHLPerrieraLKCreininMDPostplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trialObstet Gynecol201011651079108720966692
  • HayesJLCwiakCGoedkenPZiemanMA pilot clinical trial of ultrasound-guided postplacental insertion of a levonorgestrel intrauterine deviceContraception200776429229617900440
  • AllenRHBartzDGrimesDAHubacherDO’BrienPInterventions for pain with intrauterine device insertionCochrane Database Syst Rev20093CD00737319588429
  • MaguireKDavisARosario TejedaLWesthoffCIntracervical lidocaine gel for intrauterine device insertion: a randomized controlled trialContraception201286321421922325115
  • McNicholasCPMaddenTZhaoQSecuraGAllsworthJEPeipertJFCervical lidocaine for IUD insertional pain: a randomized controlled trialAm J Obstet Gynecol20122075384 .e1e623107081
  • OlotoEJBromhamDRMurtyJAPain and discomfort perception at IUD insertion – effect of short-duration, low-volume, intracervical application of two percent lignocaine gel (Instillagel) – a preliminary studyBr J Fam Plann1997224177180
  • BednarekPHMicksEAEdelmanABLiHJensenJTThe effect of nitroprusside on IUD insertion experience in nulliparous women: a pilot studyContraception201387442142523218853
  • DijkhuizenKDekkersOMHolleboomCAVaginal misoprostol prior to insertion of an intrauterine device: an RCTHum Reprod201126232332921159683
  • EdelmanABSchaeferEOlsonAEffects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous womenContraception201184323423921843686
  • HeikinheimoOInkiPKunzMDouble-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine systemContraception201081648148620472114
  • LiYTKuoTCKuanLCChuYCCervical softening with vaginal misoprostol before intrauterine device insertionInt J Gynaecol Obstet2005891676815777909
  • SaavIAronssonAMarionsLStephanssonOGemzell-DanielssonKCervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trialHum Reprod200722102647265217652452
  • SwensonCTurokDKWardKJacobsonJCDermishASelf-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trialObstet Gynecol20121202 Pt 134134722825094
  • ScavuzziASouzaASCostaAAAmorimMMMisoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trialHum Reprod20132882118212523739219
  • SufrinCBPostlethwaiteDArmstrongMAMerchantMWendtJMSteinauerJENeisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory diseaseObstet Gynecol201212061314132123168755
  • American College of Obstetricians and GynecologistsACOG Practice Bulletin No 121: Long-acting reversible contraception: implants and intrauterine devicesObstet Gynecol2011118118419621691183
  • GrimesDASchulzKFAntibiotic prophylaxis for intrauterine contraceptive device insertionCochrane Database Syst Rev20012CD00132711405986
  • NishimuraRACarabelloBAFaxonDPACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsCirculation2008118888789618663090
  • WilsonWTaubertKAGewitzMPrevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working GroupCirculation2007116151736175417446442
  • SuhonenSHaukkamaaMJakobssonTRauramoIClinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative studyContraception200469540741215105064
  • LuukkainenTToivonenJLevonorgestrel-releasing IUD as a method of contraception with therapeutic propertiesContraception19955252692768585882
  • Sitruk-WareRThe levonorgestrel intrauterine system for use in peri- and postmenopausal womenContraception200775Suppl 6S155S16017531609
  • MansourDThe benefits and risks of using a levonorgestrel-releasing intrauterine system for contraceptionContraception201285322423422067761
  • DubuissonJBMugnierEAcceptability of the levonorgestrel-releasing intrauterine system after discontinuation of previous contraception: results of a French clinical study in women aged 35 to 45 yearsContraception200266212112812204786
  • McGaviganCJDockeryPMetaxa-MariatouVHormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrelHum Reprod2003181778412525444
  • MosherWDMartinezGMChandraAAbmaJCWillsonSJUse of contraception and use of family planning services in the United States: 1982–2002Adv Data200435013615633582
  • TewariRKayVJCompliance and user satisfaction with the intrauterine contraceptive device in Family Planning Service: the results of a survey in Fife, Scotland, August 2004Eur J Contracept Reprod Health Care2006111283716546814
  • XiaoBWuSCChongJZengTHanLHLuukkainenTTherapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagiaFertil Steril200379496396912749438
  • HidalgoMBahamondesLPerrottiMDiazJDantas-MonteiroCPettaCBleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two yearsContraception200265212913211927115
  • RonnerdagMOdlindVHealth effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous useActa Obstet Gynecol Scand199978871672110468065
  • Heliovaara-PeippoSOksjokiRHalmesmakiKThe effect of hysterectomy or levonorgestrel-releasing intrauterine system on cardiovascular disease risk factors in menorrhagia patients: a 10-year follow-up of a randomised trialMaturitas201169435435821684096
  • RogovskayaSRiveraRGrimesDAEffect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trialObstet Gynecol2005105481181515802410
  • Graff-IversenSTonstadSUse of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian SurveyContraception200266171312169374
  • BahamondesLEspejo-ArceXHidalgoMMHidalgo-ReginaCTeatin-JuliatoCPettaCAA cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine systemHum Reprod20062151316131916373404
  • BahamondesMVMonteiroICastroSEspejo-ArceXBahamondesLProspective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine systemHum Reprod20102551158116420185512
  • Morin-PapunenLMartikainenHMcCarthyMIComparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general populationAm J Obstet Gynecol20081995529. e1e529. e1018533124
  • van VlietHATchaikovskiSNRosendaalFRRosingJHelmerhorstFMThe effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC)Thromb Haemost2009101469169519350113
  • LidegaardOLokkegaardEJensenASkovlundCWKeidingNThrombotic stroke and myocardial infarction with hormonal contraceptionN Engl J Med2012366242257226622693997
  • JarvelaITekayAJouppilaPThe effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile womenHum Reprod19981312337933839886518
  • BaldasztiEWimmer-PuchingerBLoschkeKAcceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up studyContraception2003672879112586318
  • InkiPHurskainenRPaloPComparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs hysterectomyUltrasound Obstet Gynecol200220438138512383322
  • Berlex LaboratoriesMirena [prescribing information]2013 Available from: http://www.berlex.com/html/products/pi/Mirena_PI.pdfAccessed July 19, 2013
  • BackmanTRauramoIJaakkolaKUse of the levonorgestrel-releasing intrauterine system and breast cancerObstet Gynecol2005106481381716199640
  • DingerJBardenheuerKMinhTDLevonorgestrel-releasing and copper intrauterine devices and the risk of breast cancerContraception201183321121721310281
  • TrinhXBTjalmaWAMakarAPBuytaertGWeylerJvan DamPAUse of the levonorgestrel-releasing intrauterine system in breast cancer patientsFertil Steril2008901172217706209
  • FarleyTMRosenbergMJRowePJChenJHMeirikOIntrauterine devices and pelvic inflammatory disease: an international perspectiveLancet199233987967857881347812
  • SivinISternJHealth during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR)Fertil Steril199461170778293847
  • ToivonenJLuukkainenTAllonenHProtective effect of intrauterine release of levonorgestrel on pelvic infection: three years’ comparative experience of levonorgestrel- and copper-releasing intrauterine devicesObstet Gynecol19917722612641899136
  • HeinemannKBarnettCDingerJRisk factors for uterine perforations during IUD insertion: interim results from the EURAS-IUD study2011 Available from: http://www.pharmacoepi.org/meetings/27thconf/presentations/Risk%20Factors%20for%20Uterine%20Perforations%20during%20IUD%20Insertion-%20Interim%20Results%20from%20the%20EURAS-IUD%20Study.pdfAccessed July 19, 2013
  • CaliskanEOzturkNDilbazBODilbazSAnalysis of risk factors associated with uterine perforation by intrauterine devicesEur J Contracept Reprod Health Care20038315015514667326
  • HeartwellSFSchlesselmanSRisk of uterine perforation among users of intrauterine devicesObstet Gynecol198361131366823347
  • FrenchRSCowanFMMansourDLevonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptivesBJOG2000107101218122511028571
  • ErogluKAkkuzuGVuralGComparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-upContraception200674537638117046378
  • GrimesDSchulzKStanwoodNImmediate postabortal insertion of intrauterine devicesCochrane Database Syst Rev20044CD00177715495018
  • Gemzell-DanielssonKSchellschmidtIApterDA randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and MirenaFertil Steril2012973616622 e1–e322222193
  • JensenJTContraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overviewObstet Gynecol Surv200560960461216121115
  • DavieJEWallingMRMansourDJBromhamDKishenMFowlerPImpact of patient counseling on acceptance of the levonorgestrel implant contraceptive in the United KingdomClin Ther19961811501598851460
  • BackmanTHuhtalaSLuotoRTuominenJRauramoIKoskenvuoMAdvance information improves user satisfaction with the levonorgestrel intrauterine systemObstet Gynecol200299460861312039121
  • InkiPLong-term use of the levonorgestrel-releasing intrauterine systemContraception200775Suppl 6S161S16617531611
  • SivinIAlvarezFDiazJIntrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devicesContraception19843054434566440740
  • CibulaDWomen’s contraceptive practices and sexual behaviour in EuropeEur J Contracept Reprod Health Care200813436237519170278
  • GarcíaICGarcíaEVRubioMTEstudio de satisfacción en usuarias españolas del DIU-LNG (Mirena)Rev Iberoam Fertil Reprod Hum2009264335342
  • LuoLLuoBZhengYZhangHLiJSidellNLevonorgestrel-releasing intrauterine system for atypical endometrial hyperplasiaCochrane Database Syst Rev20136CD00945823737032
  • LethabyAECookeIReesMProgesterone or progestogen-releasing intrauterine systems for heavy menstrual bleedingCochrane Database Syst Rev20054CD00212616235297
  • Abou-SettaAMHoustonBAl-InanyHGFarquharCLevonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgeryCochrane Database Syst Rev20131CD00507223440798
  • SangkomkamhangUSLumbiganonPLaopaiboonMMolBWProgestogens or progestogen-releasing intrauterine systems for uterine fibroidsCochrane Database Syst Rev20132CD00899423450594
  • DolapciogluKBozABalogluAThe efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative studyClin Exp Obstet Gynecol201340112212623724525
  • Abu HashimHZayedAGhayatyEEl RakhawyMLNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trialJ Gynecol Oncol201324212813423653829
  • IsmailMTFahmyDMElshmaaNSEfficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypiaReprod Sci2013201455023203322
  • WongAWChanSSYeoWYuMYTamWHProphylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trialObstet Gynecol2013121594395023635729